Etiopathogenesis of pediatric thrombosis

Hematology

Volumn 10, Issue SUPPL. 1, 2005, Pages 167-170

  Manco Johnson, Marilyn J ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Mountain States Regional Hemophilia and Thrombosis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ARTERY THROMBOSIS; CARDIOVASCULAR RISK; CATHETER THROMBOSIS; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE MUTATION; HEREDITY; HUMAN; NEWBORN PERIOD; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOPHILIA; THROMBOSIS; VEIN THROMBOSIS;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; PROTEIN C DEFICIENCY; RISK FACTORS; THROMBOPHILIA; THROMBOSIS;

EID: 29244464660     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330512331390285     Document Type: Review

References (27)

1. Richardson MW, Allen GA, Monahan PE. Thrombosis in children: current perspectives and distinct challenges. Thromb Haemost 2002;88:900-911.
2. Nowak-Göttl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost 2001;86:464-474.
3. Nuss R, Manco-Johnson M. Childhood Thrombosis. Pediatrics 1995;96:291-294.
4. Manco-Johnson MJ. Disorders of hemostasis in childhood: risk factors for venous thromboembolism. Thromb Haemost 1997;78:710-714.
5. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thrombotic Complications. J Pediatr 1998;133:770-776.
6. Nowak-Göttl U, Kosch A, Schlegel N, Salem M, Manco-Johnson M. Thromboembolism in children. Curr Opin Hematol 2002;9:448-453.
7. Manco-Johnson MJ, Nuss R. Thrombophilia in the infant and child. Advances Pediatr 2001;48:363-384.
8. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus antic-oagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-323.
9. Josephson C, Nuss R, Jacobson L, et al. The varicella-autoantibody syndrome. Pediatr Res 2001;50:345-352.
10. Nuss R, Hays T, Chudgar U, Manco-Johnson M. Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli. J Pediatr Hematol/Oncol 1997;19:202-207.
11. Manco-Johnson MJ, Nuss R. Lupus anticoagulant in children with thrombosis. Amer J Hematol 1995;48:240-243.
12. Manco-Johnson MJ, Grabowski EF, Hellgren M, et al. Laboratory testing for thrombophilia in pediatric patients. Thromb Haemost 2002;88:155-156.
13. Mathew P, Manco-Johnson M, Hutter JJ, et al. Early clot recurrence or progression is not increased in children with genetic thrombophilia - preliminary results from the Regional Thrombophilia Registry Eight and Ten (the ReTREAT Study). Blood 2003;102:548a.
14. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent thrombosis in children with combined prothrombotic risk factors. Blood 2001;97:858-862.
15. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-Dimer levels as predictors of poor outcome of thrombosis in children. New Engl J Med 2004;351:1081-1088.
16. Zimbleman J, Lefkowitz J, Schaeffer C, et al. Unusual complications of warfarin therapy: skin necrosis and priapism. J Pediatr 2000;137:266-268.
17. van Ommen CH, Heijboer H, van den Dool EJ, et al. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 2003;1:2516-2522.
18. Kuhle S, Koloshuk B, Marzinotto V, et al. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res 2003;111:227-233.
19. Häusler M, Hübner D, Delhaas T, Mühler EG. Long term complications of inferior vena cava thrombosis. Arch Dis Child 2001;85:228-233.
20. Manco-Johnson MJ, Knapp-Clevenger R, Miller B, Hays T. Post-thrombotic syndrome (PTS) in children: validationof a new pediatric outcome instrument and results in a comprehensive cohortof children with extremity deep vein thrombosis (DVT). Blood 2003;102:553a.
21. Revel-Vilk S, Sharathkumar A, Massicotte P, et al. Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost 2004;2:42-46.
22. de Veber G. Arterial ischemic strokes in infants and children: an overview of current approaches. Semin Thromb Haemost 2003;29:567-573.
23. de Veber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539-1543.
24. Markarian M, Lubchenco LO, Rosenblüt E, et al. Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. II. The effect of heparin. Biol Neonate 1971;17:98-111.
25. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003;1:263-268.
26. Streif W, Paes B, Berry L, et al. Influence of exogenous factor VIIa on thrombin generation in plasma of full-term and preterm newborns. Blood Coag Fibrinol 2000;11:349-357.
27. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-F167.